| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.092 | 0.08 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |